Vipin Kumar (Chaturvedi)

Title(s)Professor, Medicine
SchoolHealth Sciences
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kanpur University, IndiaBS with Honors1978Biology
    Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaMSc1980Biochemistry, Molecular Biology and Immunology
    Indian Institute of Science, Bangalore, IndiaPhD1986Biochemistry
    Harvard University, BostonResearch Fellowship1987Pharmacology
    California Institute of Technology, PasadenaNational Multiple Sclerosis Society Senior Postdoctoral Fellowship1991Biology
    University of California, Los AngelesFellowship1993Microbiology and Molecular Genetics

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ware R, Kumar V. Complexity and function of natural killer T cells with potential application to hepatic transplant survival. Liver Transpl. 2017 12; 23(12):1589-1592. PMID: 28945950.
      View in: PubMed
    2. Ying G, Wang J, Kumar V, Zajonc DM. Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide. PLoS One. 2017; 12(8):e0182296. PMID: 28767728.
      View in: PubMed
    3. Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017 May 01; 312(5):G413-G419. PMID: 28232456.
      View in: PubMed
    4. Dhodapkar MV, Kumar V. Type II NKT Cells and Their Emerging Role in Health and Disease. J Immunol. 2017 02 01; 198(3):1015-1021. PMID: 28115591.
      View in: PubMed
    5. Dasgupta S, Kumar V. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset. Immunogenetics. 2016 Aug; 68(8):665-76. PMID: 27405300.
      View in: PubMed
    6. Marrero I, Aguilera C, Hamm DE, Quinn A, Kumar V. High-throughput sequencing reveals restricted TCR Vß usage and public TCRß clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes. Mol Immunol. 2016 06; 74:82-95. PMID: 27161799.
      View in: PubMed
    7. Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol. 2016 05; 13(3):337-46. PMID: 26972772.
      View in: PubMed
    8. Marrero I, Ware R, Kumar V. Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer. Front Immunol. 2015; 6:316. PMID: 26136748; PMCID: PMC4470258.
    9. Read M, Andrews PS, Timmis J, Williams RA, Greaves RB, Sheng H, Coles M, Kumar V. Correction: Determining disease intervention strategies using spatially resolved simulations. PLoS One. 2015; 10(5):e0128170. PMID: 25955716; PMCID: PMC4425704.
    10. Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V. Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology. 2015 Apr; 61(4):1357-69. PMID: 25477000; PMCID: PMC4376634.
    11. Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B. Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol. 2016 Mar; 13(2):206-16. PMID: 25661730; PMCID: PMC4786627.
    12. Maricic I, Girardi E, Zajonc DM, Kumar V. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. J Immunol. 2014 Nov 01; 193(9):4580-9. PMID: 25261475; PMCID: PMC4201983.
    13. Kumar V, Delovitch TL. Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology. 2014 Jul; 142(3):321-36. PMID: 24428389; PMCID: PMC4080948.
    14. Maricic I, Halder R, Bischof F, Kumar V. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis. J Immunol. 2014 Aug 01; 193(3):1035-46. PMID: 24973441; PMCID: PMC4110642.
    15. Kumar V. NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol. 2013 Sep; 59(3):618-20. PMID: 23669283; PMCID: PMC4086465.
    16. Viale R, Ware R, Maricic I, Chaturvedi V, Kumar V. NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation. Curr Immunol Rev. 2012 Nov 01; 8(4):287-296. PMID: 25288922.
      View in: PubMed
    17. Girardi E, Maricic I, Wang J, Mac TT, Iyer P, Kumar V, Zajonc DM. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat Immunol. 2012 Sep; 13(9):851-6. PMID: 22820602; PMCID: PMC3442777.
    18. Subramanian L, Blumenfeld H, Tohn R, Ly D, Aguilera C, Maricic I, Mansson JE, Buschard K, Kumar V, Delovitch TL. NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]. PLoS One. 2012; 7(5):e37771. PMID: 22649557; PMCID: PMC3359325.
    19. Arrenberg P, Maricic I, Kumar V. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology. 2011 Feb; 140(2):646-55. PMID: 20950612; PMCID: PMC3114423.